M. Arlen et Ky. Tsang, MONOCLONAL-ANTIBODIES AND THEIR ROLE IN MODULATION OF THE IMMUNE-RESPONSE, Journal of surgical oncology, 54(2), 1993, pp. 103-108
Clinical studies in patients having been vaccinated with immunogenic g
lycoproteins suggest that a monoclonal antibody response is important
in helping to induce cell mediated tumor destruction. Such a monoclona
l response was noted to characterize the reaction to several different
immunogenic antigens administered in an adjuvant setting. The resulti
ng cell mediated reaction appeared to be associated with concomittant
antibody dependent cell mediated cytotoxicity (ADCC) and an anti-idiot
ype monoclonal response. Both 31.1 and 33.28 protein derived colon car
cinoma monoclonal antibodies have been found to be capable of turning
on natural killer (NK) cell activity as part of ADCC. In vivo studies
with specific antigens to induce an anti-tumor response have suggested
that the mechanism of tumor cell destruction is complex and associate
d with T-cell activation, anti-idiotype production, and complement bin
ding on the tumor membrane. (C) 1993 Wiley-Liss, Inc.